Lou Yu Yan
Director/Board Member chez ESLITE SPECTRUM CORPORATION
Profil
Lou Yu Yan currently works at Qisda Corp., as Independent Director from 2020, Sinyi Realty, Inc., as Independent Director from 2017, ANZ Banking Corp., as Independent Director, and The Eslite Spectrum Corp., as Independent Director.
Mr. Yan also formerly worked at Chunghwa Telecom Co., Ltd., as Independent Director and Crown Bioscience International, as Independent Director.
Mr. Yan received his graduate degree from National Chengchi University.
Postes actifs de Lou Yu Yan
| Sociétés | Poste | Début |
|---|---|---|
| ESLITE SPECTRUM CORPORATION | Director/Board Member | - |
| SINYI REALTY INC. | Director/Board Member | 26/05/2017 |
| QISDA CORPORATION | Director/Board Member | 19/06/2020 |
ANZ Banking Corp.
 ANZ Banking Corp. Regional BanksFinance ANZ Banking Corp. provides commercial banking services. The company is headquartered in Northcote, Australia. | Director/Board Member | - |
Anciens postes connus de Lou Yu Yan
| Sociétés | Poste | Fin |
|---|---|---|
| CHUNGHWA TELECOM CO., LTD. | Director/Board Member | - |
| CROWN BIOSCIENCE INTERNATIONAL | Director/Board Member | - |
Formation de Lou Yu Yan
| National Chengchi University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| CHUNGHWA TELECOM CO., LTD. | Communications |
| QISDA CORPORATION | Electronic Technology |
| SINYI REALTY INC. | Finance |
| ESLITE SPECTRUM CORPORATION | Finance |
| Entreprise privées | 2 |
|---|---|
ANZ Banking Corp.
ANZ Banking Corp. Regional BanksFinance ANZ Banking Corp. provides commercial banking services. The company is headquartered in Northcote, Australia. | Finance |
Crown Bioscience International
 Crown Bioscience International BiotechnologyHealth Technology Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan. | Health Technology |
